Latest data shows upward trajectory for avoidable MS emergency admissions continues

3 February, 2020 | Posted in:

The latest Hospital Episode Statistics (HES) data shows that emergency hospital admissions for people with multiple sclerosis (MS) continue to rise despite many of them being avoidable through preventative care.  MS Academy have partnered with healthcare intelligence provider Wilmington Healthcare to analyse the latest HES data and compare it to the previous two years, and […]

Continue Reading »

One night of poor sleep can increase Alzheimer’s biomarker

10 January, 2020 | Posted in:

An initial study has found that depriving healthy young men of just one night of sleep can increase their levels of the protein tau found in their blood, as compared to an uninterrupted night’s rest. Tau, a known biomarker for Alzheimer’s disease is found in neurons and can form into tangles which accumulate in the […]

Continue Reading »

Quarter of people with Parkinson’s are misdiagnosed with another condition

3 January, 2020 | Posted in:

A survey commissioned by Parkinson’s UK has found that a quarter of people living with Parkinson’s were initially misdiagnosed with a different condition, from stroke to anxiety.  The survey of over 2,000 people living with Parkinson’s found that 26% of people were initially wrongly diagnosed with a different condition, whilst 21% were only referred to […]

Continue Reading »

New year, new MasterClasses!

3 January, 2020 | Posted in: , ,

This year we are excited to announce two new MasterClasses to our range of educational offerings: the Leadership MasterClass and the Alzheimer’s MasterClass.  Leadership MasterClass Our Leadership MasterClass will commence with its first nine delegates this February and promises to be an exciting and innovative course, drawing on interactive workshops, coaching techniques and a practical […]

Continue Reading »

Extending our reach – transforming care through increasing forms of education

18 December, 2019 | Posted in:

By Sarah Gillett, Managing Director What an incredible year it has been for Neurology Academy! January kicked off with us being shortlisted for Best Educational Programme for the NHS within the the prestigious HSJ awards. Our entry, ‘Addressing variation in MS services nationally through clinical engagement and collaboration’ focussed on our national programme to ‘raise […]

Continue Reading »

Palliative Care MasterClass – Winter update

18 December, 2019 | Posted in:

By Dr Ed Richfield, Academy Faculty The potential for palliative approaches to benefit people with neurological conditions is increasingly recognised. The Movement Disorder Society (MDS) now has a palliative care task force specifically examining this area, and the first trial of integrated palliative care for Parkinson’s Disease (PD) reported provisional results at the conference in […]

Continue Reading »

Neuropharmacy: new specialism, new MasterClass

13 December, 2019 | Posted in: ,

By Joela Mathews, Neuropharmacist and faculty member The newest branch of the Neurology Academy, Neuropharmacy Academy saw 14 delegates graduate in 2019. Created in response to this growing specialist discipline, the course is split across two MasterClass modules which cover multiple sclerosis (MS), headache disorders, epilepsy and Parkinson’s.  Following the tried and tested practical education […]

Continue Reading »

Bionic Neurons Could Replace Failing Brain Circuits

10 December, 2019 | Posted in:

Artificial neurons are being developed which could be implanted into patients with failing brain circuits. This revolutionary process could help patients overcome paralysis, alzheimers and even the aging process. The bionic neurons are capable of interacting with the healthy nerve cells, receiving and processing electrical signals before sending new signals out to the rest of […]

Continue Reading »

First ever NICE guidance on cannabis-based medicinal products

18 November, 2019 | Posted in: ,

NICE has published its first ever guidance on cannabis-based medicinal products. NG144 has just been published this November and outlines guidance across 4 key areas (fig 1): chemotherapy-induced nausea and vomiting, chronic pain, spasticity, and treatment-resistant epilepsy.  The National Council of Health and Care Excellence (NICE) have examined the evidence for the use of both […]

Continue Reading »

Second Neuropharmacy MasterClass launches for 2020

15 November, 2019 | Posted in:

The Neurology Academy are excited to launch the second of our Neuropharmacy MasterClasses for 2020. The MasterClass, designed for specialist pharmacists who are already working in neurology, has been created in response to the growing role and remit of the neuropharmacist. The two module course is ideal for those who are already specialists and want […]

Continue Reading »